Objectives To investigate the efficacy of an advanced transurethral th
ermotherapy (TUMT) device (T3, Urologix) using urodynamic analysis in
addition to the standard evaluation protocol in patients with symptoma
tic benign prostatic hyperplasia (BPH). Patients and methods Fifty men
with symptomatic BPH were assessed using the AUA symptom score, urofl
owmetry and ultrasonography (to determine prostatic volume and residua
l urinary volume) before and 6 weeks, 3, 6 and 12 months after thermot
herapy. TUMT was delivered using a focused microwave energy system for
1 h in each patient, treated on an out-patient basis, Video pressure
Bow studies with advanced urodynamic analysis were also performed befo
re and 3 months after treatment. Results The mean AUA symptom score de
creased by 63%, the mean peak Bow rate increased by 64% and the post-v
oid residual volume decreased by 30% 3 months after treatment; this im
provement was maintained at one year after treatment. Advanced urodyna
mic analysis showed that 52% of the patients had a decreased severity
of obstruction. Furthermore, the efficiency of detrusor contraction im
proved in 86% of the patients. The improvement in the symptom score, n
ow rate and residual urine was significantly better in patients with m
arginal obstruction than in patients with unequivocal obstruction. Con
clusion Urodynamic analysis can predict the treatment outcome of TUMT
and the results of thermotherapy are significantly better in patients
with marginal prostatic bladder outflow obstruction.